MedPath

EECP and HRV in ischemic stroke

Phase 2
Conditions
Health Condition 1: G94- Other disorders of brain in diseases classified elsewhere
Registration Number
CTRI/2023/11/060112
Lead Sponsor
J M Janani
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Based on an Age-appropriate SDNN value

Age: 20 and 65 years

Both genders

First-ever ischemic stroke

Exclusion Criteria

History of Atrial fibrillation and Rheumatic heart disease.

History of Arteriovenous Fistula, Arteriovenous Malformation,

A history of Haemorrhage, Malignancy

Sustained hypertension (systolic BP >180 mm Hg or diastolic BP >100 mm Hg)

History of Systemic diseases (Thrombocytopenia, Renal failure, cirrhosis)

History of Severe symptomatic peripheral vascular disease (PVD) (lower extremity Vaso-occlusive disease)

Pregnant woman

Diabetic mellitus ( > 5yrs)

Bleeding diathesis, Active thrombophlebitis

Complex regional pain syndrome (CRPS)

Obesity (BMI: 30-39.99 kg/m2)

Apraxia

Patients who are under medication of Beta-blockers, anticholinergic, muscle relaxants, antiadrenergic, and diuretics drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Heart rate variability <br/ ><br>Time domain <br/ ><br>a) SDNN & SDNN Index. <br/ ><br>Frequency domain <br/ ><br>a) VLF, HF, & LF. <br/ ><br>Heart rate (bpm) <br/ ><br>Timepoint: For 35 day during intervention and follow up after 1 month and 3 months
Secondary Outcome Measures
NameTimeMethod
Blood Pressure – SBP & DBP <br/ ><br>Variations in diastolic BP (mmHg)Timepoint: For 35 days during intervention & follow up after 1 month & 3 months
© Copyright 2025. All Rights Reserved by MedPath